Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-016974
Filing Date
2020-04-16
Accepted
2020-04-16 08:59:00
Documents
167
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F asln-20f_20191231.htm 20-F 6394151
2 EX-2.4 asln-ex24_492.htm EX-2.4 275996
3 EX-4.8 asln-ex48_485.htm EX-4.8 1076954
4 EX-8.1 asln-ex81_490.htm EX-8.1 15589
5 EX-12.1 asln-ex121_489.htm EX-12.1 23193
6 EX-12.2 asln-ex122_488.htm EX-12.2 23397
7 EX-13.1 asln-ex131_486.htm EX-13.1 10378
8 EX-13.2 asln-ex132_487.htm EX-13.2 9835
9 GRAPHIC gn534nos0qwq000009.jpg GRAPHIC 47792
10 GRAPHIC gpycaw3ri2vd000008.jpg GRAPHIC 9159
11 GRAPHIC gn534nos0qwq000003.jpg GRAPHIC 2393
12 GRAPHIC gpycaw3ri2vd000012.jpg GRAPHIC 1270
13 GRAPHIC gn534nos0qwq000006.jpg GRAPHIC 4474
14 GRAPHIC gpycaw3ri2vd000014.jpg GRAPHIC 27159
15 GRAPHIC gn534nos0qwq000002.jpg GRAPHIC 2382
16 GRAPHIC gpycaw3ri2vd000002.jpg GRAPHIC 9433
17 GRAPHIC gn534nos0qwq000008.jpg GRAPHIC 3522
18 GRAPHIC gn534nos0qwq000014.jpg GRAPHIC 1823
19 GRAPHIC gpycaw3ri2vd000009.jpg GRAPHIC 6996
20 GRAPHIC gpycaw3ri2vd000004.jpg GRAPHIC 16053
21 GRAPHIC gpycaw3ri2vd000001.jpg GRAPHIC 33122
22 GRAPHIC gn534nos0qwq000010.jpg GRAPHIC 47792
23 GRAPHIC gpycaw3ri2vd000010.jpg GRAPHIC 14914
24 GRAPHIC gpycaw3ri2vd000005.jpg GRAPHIC 29390
25 GRAPHIC gn534nos0qwq000001.jpg GRAPHIC 4474
26 GRAPHIC gn534nos0qwq000007.jpg GRAPHIC 2393
27 GRAPHIC gpycaw3ri2vd000013.jpg GRAPHIC 23461
28 GRAPHIC gn534nos0qwq000011.jpg GRAPHIC 928
29 GRAPHIC gn534nos0qwq000005.jpg GRAPHIC 2382
30 GRAPHIC gpycaw3ri2vd000011.jpg GRAPHIC 973
31 GRAPHIC gpycaw3ri2vd000003.jpg GRAPHIC 9077
32 GRAPHIC gpycaw3ri2vd000006.jpg GRAPHIC 16064
33 GRAPHIC gpycaw3ri2vd000007.jpg GRAPHIC 11672
34 GRAPHIC gn534nos0qwq000004.jpg GRAPHIC 47792
35 GRAPHIC gn534nos0qwq000013.jpg GRAPHIC 928
36 GRAPHIC gn534nos0qwq000012.jpg GRAPHIC 2120
  Complete submission text file 0001564590-20-016974.txt   22077828

Data Files

Seq Description Document Type Size
37 XBRL INSTANCE DOCUMENT asln-20191231.xml EX-101.INS 5050968
38 XBRL TAXONOMY EXTENSION SCHEMA asln-20191231.xsd EX-101.SCH 127693
39 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asln-20191231_cal.xml EX-101.CAL 85720
40 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asln-20191231_def.xml EX-101.DEF 355940
41 XBRL TAXONOMY EXTENSION LABEL LINKBASE asln-20191231_lab.xml EX-101.LAB 702080
42 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asln-20191231_pre.xml EX-101.PRE 607239
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38475 | Film No.: 20795294
SIC: 2834 Pharmaceutical Preparations